India's first heart failure registry reveals younger patients, high mortality rates, and varying causes of heart failure.

They are also at greater risk for other heart, brain and cognitive issues  TORONTO, Feb. 4, 2025  According to a new report ...

Eko Health has been advancing the use of artificial intelligence to help providers detect the early signs of disease, ...

Transplantation remains the only therapeutic option for selected patients with advanced pulmonary arterial ... ventricular dysfunction, or congenital heart disease with complex or ventricular ...

Patients with congenital heart disease associated PAH tend to ... FC: Functional class; iPAH: Idiopathic pulmonary arterial hypertension; iv.: Intravenous; NYHA: New York Heart Association ...

A scientific statement regarding CPET interpretation in patients with congenital HD across their lifespan has been published by the AHA.

Merck to stop phase 3 HYPERION trial evaluating Winrevair early and move to final analysis: Rahway, New Jersey Friday, January 31, 2025, 10:00 Hrs [IST] Merck, known as MSD outsid ...

A new report from the Heart and Stroke Foundation shows that Canadians with congenital heart disease are living longer than ...

About PAH Pulmonary arterial hypertension (PAH ... 40,000 people in the U.S. are living with PAH. The disease progresses rapidly for many patients. PAH results in significant strain on the heart, ...

Merck , known as MSD outside of the United States and Canada, announced today the Phase 3 HYPERION study evaluating WINREVAIR (sotatercept-csrk) versus placebo (both in combination with background ...